Immucell (ICCC) Asset Utilization Ratio (2009 - 2026)
Immucell's Asset Utilization Ratio came in at 0.70 for Q3 2026, up 7.5% from 0.65 a year earlier and up 3.9% from the prior quarter.
Analysis
Immucell (ICCC) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
For FY2025, Immucell's Asset Utilization Ratio was 0.63, up 5.9% from FY2024.
- Going back by year, Asset Utilization Ratio was 0.60 in FY2024 (+51.2%), 0.39 in FY2023 (-5.2%), 0.42 in FY2022 (-8.4%) and 0.45 in FY2021 (+16.9%).
- The Q3 2026 figure represents the highest quarterly Asset Utilization Ratio since Q4 2015.
- Year-over-year, Asset Utilization Ratio has increased for 11 consecutive quarters, with growth averaging 38.9% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q4 2024 (growth of 111.2%), and the weakest in Q4 2023 (a decline of 31.2%).
- Business Quant data shows ICCC's Asset Utilization Ratio at 0.68 (Q2 2026), 0.69 (Q1 2026) and 0.65 (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 0.31 |
| 10 | Immucell | 102.43 Mn | 75.03 Mn | 3.56 Mn | 0.70 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.70 |
| Jun 30, 2026 | 0.68 |
| Mar 31, 2026 | 0.69 |
| Dec 31, 2025 | 0.63 |
| Sep 30, 2025 | 0.63 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 0.60 |
| Dec 31, 2024 | 0.59 |
| Sep 30, 2024 | 0.43 |
| Jun 30, 2024 | 0.43 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.28 |
| Sep 30, 2023 | 0.37 |
| Jun 30, 2023 | 0.36 |
| Mar 31, 2023 | 0.36 |
| Dec 31, 2022 | 0.41 |
| Sep 30, 2022 | 0.44 |
| Jun 30, 2022 | 0.44 |
| Mar 31, 2022 | 0.46 |
| Dec 31, 2021 | 0.43 |
API Access
Immucell Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ICCC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ICCC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ICCC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();